The pharmacodynamics and pharmacokinetics of a novel thromboxane receptor blocking drug vapiprost (GR32191) after single intravenous doses in healthy subjects.-Reference-Cited by-同舟云学术

The pharmacodynamics and pharmacokinetics of a novel thromboxane receptor blocking drug vapiprost (GR32191) after single intravenous doses in healthy subjects.

Published:1991-08 Issue:2 Volume:32 Page:181-186
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:British Journal of Clinical Pharmacology

Author:

Thomas M,Keery RJ,Charter MK,Scully NL,Chilton JE,Lumley P

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2125.1991.tb03879.x/fullpdf

Reference10 articles.

1. Characteristics of [3H]-GR32191 binding to the thromboxane (TP) receptor of human platelets;Armstrong;Br. J. Pharmac. Proc.,1989

2. Reduction in the number of tromboxane receptors (Bmax) on human platelets after exposure to GR32191;Armstrong;Br. J. Pharmac. Proc.,1990

3. The estimation of moments: a technical note;Charter;J. Pharmacokin. Biopharm.,1989

4. Vapiprost (GR32191);Lumley;Drugs of the Future,1990

5. A method for quantifying platelet aggregation and analysing drug-receptor interactions on platelets in whole blood in vitro;Lumley;J. pharmac. Methods,1981

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Myocardial hypertrophy associated with long-term phenylpropanolamine use in a dog;Journal of the American Veterinary Medical Association;2018-12

2. Qualitative Determination of Known Thromboxane Receptors in Human Plasma by LC-MS (Quadrupole Time of Flight);Asian Journal of Chemistry;2013

3. Therapeutic management of allergic diseases;Drug Metabolism Reviews;2009-07-15

4. How to ‘Melt the Ice’ on the Streets: A Social-Control Analysis on the Rise of Methamphetamine within Australia and the Need to Reduce Demand;Current Issues in Criminal Justice;2009-03

5. Citrus aurantium and synephrine alkaloids in the treatment of overweight and obesity: an update;Obesity Reviews;2006-02